Aveanna Healthcare Hldgs Stock (NASDAQ:AVAH), Analyst Ratings, Price Targets, Predictions

The latest price target for Aveanna Healthcare Hldgs (NASDAQ: AVAH) was reported by Deutsche Bank on March 18, 2024. The analyst firm set a price target for $3.00 expecting AVAH to rise to within 12 months (a possible 32.16% upside). 7 analyst firms have reported ratings in the last year.

The latest analyst rating for Aveanna Healthcare Hldgs (NASDAQ: AVAH) was provided by Deutsche Bank, and Aveanna Healthcare Hldgs maintained their buy rating.

There is no last upgrade for Aveanna Healthcare Hldgs.

The last downgrade for Aveanna Healthcare Holdings Inc happened on December 13, 2023 when JP Morgan changed their price target from N/A to N/A for Aveanna Healthcare Holdings Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aveanna Healthcare Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aveanna Healthcare Hldgs was filed on March 18, 2024 so you should expect the next rating to be made available sometime around March 18, 2025.

While ratings are subjective and will change, the latest Aveanna Healthcare Hldgs (AVAH) rating was a maintained with a price target of $2.00 to $3.00. The current price Aveanna Healthcare Hldgs (AVAH) is trading at is $2.27, which is within the analyst’s predicted range.